contact us on e-mail: we@nosamplio.com
contact us on e-mail: we@nosamplio.com
nosamplio has supported numerous human health brands including medicines, injectables, medical devices, aesthetics devices, cosmetics, botanicals & nutraceuticals
nosamplio provides professional insight for human health projects including strategic planning, market access, patient access, launch, re-launch & commercial strategies
we have sector expertise supporting Korean, Taiwanese, Chinese & Japanese companies reach their target audience in Europe, MENA & the Americas
ATGC Co., Ltd. License Agreement Grants RELIFE S.r.l. Exclusive Rights to Register, Promote, Distribute, and Market the Novel Botulinum Toxin Type A (ATGC-100) in Europe and the United Kingdom. www.relifecompany.com
Nosamplio provided ATGC with specialist pharmaceutical out-licensing consultancy to secure the Exclusive European Licensing Agreement with RELIFE
ATGC is an advanced biotechnology company, Korea based R&D with a pipeline of pharmaceutical projects. ATGC developed ATGC-100 a novel botulinum toxin type A for medical aesthetics indications www.atgcbio.com
Business development services for a large-cap Korean pharmaceutical company
Business development & Licensing for Korean pharmaceutical companies
Highly effective, easy-to-drink bowel preparation, on-the-day of colonoscopy for patient convenience
Licensing Life Science© nosamplio
Founding Principal of nosamplio
mob: +44(0) 7714 777 727
Giuseppe is a qualified medical practitioner with extensive Country specific pharmaceutical compliance experience
Frankie has extensive European & global pharmaceutical marketing experience. He provides nosamplio clients with strategic marketing and forecasting insights
Phil has significant pharmaceutical & medical device partnerships experience. He provides nosamplio clients with support for Business Development & Licensing projects
Steve is MD of Audience Healthcare a markets & target customer insights provider
Jack provides in-house business development & legal expertise. His experience includes pharmaceutical intellectual property. Jack is LLB Law (York, Eng)
Harrison provides in-house social, digital and traditional marketing and communications services for nosamplio & our clients
licensing life sciences© medical device & pharmaceutical BD&L
Nosamplio Limited
Registered in England, Company number 12034395
EORI: GB344603024000. ICO Registered ZB113191
© 2018 Nosamplio Limited - All Rights Reserved
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.